None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent tissue expander implantation immediately after mastectomy and whose age ranged from 20 to 70 years and who had American society of anesthesiology classification 1 or 2
Exclusion criteria
Exclusion criteria: Patients with a previous history of hypersensitivity reactions or side effects, patients with a history of drug abuse, patients with chronic pain disease or psychologic disorder, anti-depressant, creatinine 2.0 mg /dl, platelets <50,000 /ul, activated prothrombin time > 40 seconds, prothrombin ratio (international normalized ratio) > 1.5
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intravenous patient-controlled analgesia usage for 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 24 hours after surgery Maximum numeric rating scaleuntil the time of surgery, nausea and vomiting/ presence or abscence of surgical site pain for 3 and 6 months after surgery | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center